secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001193125-24-038506
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology discloses 2023 executive bonuses in amended summary comp table
--------------------------------------------------------------------------

- CEO Arthur Kuan awarded $189,000 performance bonus for 2023; total comp $3.93M.
- COO Ambaw Bellete received $189,500 sign-on bonus plus $179,740 performance bonus; total $3.03M.
- CMO Vijay Kasturi received $56,000 sign-on bonus plus $87,448 performance bonus; total $2.44M.
- Bonuses omitted from Jan 2024 IPO prospectus; now reported in Item 5.02 filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000119312524038506/0001193125-24-038506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000119312524038506/d773011d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-038506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer